Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series
Ann Card Anaesth
;
2022 Sep; 25(3): 359–361
Artículo
| IMSEAR
| ID: sea-219240
ABSTRACT
Catecholamine?resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for the treatment of isolated PVS. All patients achieved their MAP goal and the majority showed improvement in lactate and background catecholamine dose; however, variables of perfusion changed discordantly. Three of six patients survived to hospital discharge.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
Ann Card Anaesth
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS